Learning from 7 Years of Experience with Sorafenib in Advanced HCC: Sorafenib Better than Sorafenib?

Faivre, S.,de Gramont, A.,Raymond, E.; Target Oncol. 2016 Mar 22.

Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas.

Goutagny, S.,Raymond, E.,Esposito-Farese, M.,Trunet, S.,Mawrin, C.,Bernardeschi, D.,Larroque, B.,Sterkers, O.,Giovannini, M.,Kalamarides, M.; J. Neurooncol.. 2015 Jan 09.

Benzofuran derivatives as anticancer inhibitors of mTOR signaling.

Salomé, C.,Ribeiro, N.,Chavagnan, T.,Thuaud, F.,Serova, M.,de Gramont, A.,Faivre, S.,Raymond, E.,Désaubry, L.; Eur J Med Chem. 2014 May 20.